IRMD
IRadimed Corporation · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth -30.0% ·
share flow -6.4% ·
net new positions -20.0%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 83 | -3 | 5.35M | $511.40M | +6 | −8 |
| Q1 2026 | 88 | +3 | 5.07M | $488.33M | +6 | −3 |
| Q4 2025 | 85 | 0 | 4.93M | $479.86M | +1 | −1 |
| Q3 2025 | 16 | +1 | 3.09M | $220.20M | +1 | — |
| Q2 2025 | 12 | +2 | 2.63M | $157.45M | +2 | — |
| Q1 2025 | 7 | -1 | 1.04M | $54.42M | — | −1 |
| Q4 2024 | 8 | +1 | 1.01M | $55.33M | +1 | — |
| Q3 2024 | 6 | -3 | 875.49K | $44.03M | — | −3 |
| Q2 2024 | 9 | — | 935.05K | $41.09M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 539.50K | -3.7% | $27.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 188.89K | -0.8% | $9.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 188.89K | -0.8% | $9.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Millennium Management ✦ | 80.23K | -3.4% | $4.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Two Sigma Investments ✦ | 40.42K | +1.3% | $2.03M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 15.95K | +94.5% | $802,075 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 10.50K | +24.5% | $528,198 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 10.50K | +24.5% | $528,198 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 10.50K | +24.5% | $528,198 | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Citadel Advisors | $779,935 | was 0.0% |
| Norges Bank | $725,010 | was 0.0% |
| Marshall Wace | $462,731 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 225 holders, 7.61M shares, $667.38M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.